VolitionRX Limited

VolitionRX Limited

AAMEX:VNRX
0.20
USD
-0.03
(-13.13%)
-3.73EPS
16.26MMarket Cap
Mar 30Next Earn

Total Valuation

USD

As of June 30, 2026, VolitionRX Limited carries a market capitalization of 16.26M, placing it among publicly traded companies globally. Its enterprise value stands at 23.50M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap16.26M
Enterprise Value23.50M

Important Dates

VolitionRX Limited's next confirmed earnings release is scheduled for March 30, 2027.

Earnings Date3/30/2027

Share Statistics

As of June 30, 2026, VolitionRX Limited has 12.04M shares outstanding.

Shares Outstanding12.04M

Valuation Ratios

These figures are as of June 30, 2026. The price-to-sales ratio is 3.78, and the price-to-book ratio stands at -0.51.

PS Ratio3.78
PB Ratio-0.51
P/TBV Ratio-0.50
P/FCF Ratio-0.47
P/OCF Ratio-0.48

Enterprise Valuation

These figures are as of June 30, 2026. The EV/Sales ratio of 9.56 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 23.50M versus a market cap of 16.26M, with the gap driven by net debt and cash on the balance sheet.

EV / Sales9.56

Financial Position

As of June 30, 2026, VolitionRX Limited maintains a current ratio of 0.30, meaning it holds 0.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -34.02, indicating conservative leverage, while an interest coverage ratio of -4.99 demonstrates limited ability to service its debt obligations.

Current Ratio0.30
Quick Ratio0.23
Debt / Equity-34.02
Debt / EBITDA-0.62
Interest Coverage-4.99

Financial Efficiency

USD

These figures cover the twelve months ended June 30, 2026. Return on assets (ROA) is negative at -301.54, reflecting losses generated across the asset base. The company generates approximately 31,716.70 in revenue per employee across its workforce of 77.50, a quick read on workforce productivity versus industry peers.

Return on Assets (ROA)-301.54
Revenue Per Employee31,716.70
Employee Count77.50

Stock Price Statistics

USD

As of the close on November 16, 2026, VolitionRX Limited's stock has declined approximately 96.98% over the past 52 weeks. The 50-day moving average sits at 0.23, while the 200-day moving average is 1.87.

52-Week Price Change-96.98%
50-Day Moving Average0.23
200-Day Moving Average1.87

Income Statement

USD

Over the twelve months ended June 30, 2026, VolitionRX Limited generated 2.46M in revenue and converted that into -25.64M in net income, yielding earnings per share of -3.73. EBITDA reached -18.29M, while operating income came in at -19.03M.

Revenue2.46M
Operating Income-19.03M
Pretax Income-25.73M
Net Income-25.64M
EBITDA-18.29M
EBIT-19.42M
Earnings Per Share (EPS)-3.73

Balance Sheet

USD

As of June 30, 2026, VolitionRX Limited holds 2.79M in cash and equivalents against 11.41M in total debt, resulting in a net debt position of 7.92M. Total book value stands at -32.16M, with working capital of -9.40M providing operational flexibility.

Cash & Cash Equivalents2.79M
Total Debt11.41M
Net Debt7.92M
Equity (Book Value)-32.16M
Book Value Per Share-2.67
Working Capital-9.40M

Cash Flow

USD

VolitionRX Limited produced -19.56M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -21,969.00 in capital expenditures, free cash flow totaled -19.58M - equivalent to -2.84 per share.

Operating Cash Flow-19.56M
Capital Expenditures-21,969.00
Free Cash Flow-19.58M
FCF Per Share-2.84

Margins

These figures cover the twelve months ended June 30, 2026. The operating margin of -774.21 and net profit margin of -1,043.11 provide insight into operational efficiency.

Operating Margin-774.21
Pretax Margin-1,046.83
Profit Margin-1,043.11
EBITDA Margin-744.28

Dividends & Yields

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -210.56: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -125.16, meaning VolitionRX Limited raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Shareholder Yield-125.16
FCF Yield-210.56

Stock Splits

VolitionRX Limited's most recent stock split took place on April 28, 2026 with a 20:1 split ratio.

Last Split Date4/28/2026
Split Ratio20:1

Scores

As of June 30, 2026, VolitionRX Limited has an Altman Z-Score of -55.54, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-55.54